TRPV3 drives lung injury by sensing inflammatory signals to disrupt alveolar epithelial barrier and promote inflammation
- 9 October 2026
- journal article
- Published by Wiley in British Journal of Pharmacology
Abstract
Background and Purpose: Pulmonary inflammation is a central pathological feature of many respiratory diseases. Transient receptor potential vanilloid 3 (TRPV3), a non‐selective cation channel abundantly expressed in the skin, nerve and lung tissues, is involved in itch, skin inflammation and barrier regulation. However, its function in the pulmonary system remains elusive. We aimed to determine whether and how TRPV3 is involved in pulmonary inflammation. Experimental Approach: Lipopolysaccharide (LPS) and carvacrol were used to model acute lung injury (ALI) in C57BL/6J mice. Histology, bronchoalveolar lavage fluid analysis, qPCR, Western blotting, immunofluorescence, Ca 2+ imaging, transepithelial electrical resistance and FITC‐dextran permeability assays were used to assess inflammatory cell infiltration, cytokine expression, intracellular Ca 2+ changes and epithelial barrier integrity. Key Results: TRPV3 expression is markedly up‐regulated in lung tissues of ALI mice. Pharmacological activation of TRPV3 by carvacrol triggers features of ALI. Genetic deletion or pharmacological inhibition of TRPV3 significantly attenuated LPS‐ or carvacrol‐induced lung injury. Activating TRPV3 in cultured alveolar epithelial cells increased intracellular Ca 2+ , boosted cytokine/chemokine production, disrupted tight junctions, reduced transepithelial electrical resistance and increased epithelial permeability. TNF‐α augmented TRPV3 Ca 2+ responses, and inhibition of TRPV3 activity or suppression of TRPV3 expression abolished TNF‐α‐induced production of cytokines/chemokines and tight junction disruption. Conclusions and Implications: TRPV3 senses inflammatory signals to augment inflammation and disrupt tight junctions in alveolar epithelial cells, making it a promising molecular target to develop treatments for pulmonary inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (82675098)
- National Natural Science Foundation of China (81972960)
- National Natural Science Foundation of China (82373929)
This publication has 67 references indexed in Scilit:
- Review on the pharmacological effects and pharmacokinetics of scutellareinArchiv der Pharmazie, 2024
- Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung InjuryInflammation, 2022
- A review of inflammatory mechanism in airway diseasesInflammation Research, 2018
- Carvacrol and human health: A comprehensive reviewPhytotherapy Research, 2018
- A NewTRPV3Missense Mutation in a Patient With Olmsted Syndrome and ErythromelalgiaJAMA Dermatology, 2014
- Thermally Activated TRPV3 Channels2014
- Exome Sequencing Reveals Mutations in TRPV3 as a Cause of Olmsted SyndromeThe American Journal of Human Genetics, 2012
- TRP Channel Regulates EGFR Signaling in Hair Morphogenesis and Skin Barrier FormationCell, 2010
- TRPV3, a thermosensitive channel is expressed in mouse distal colon epitheliumBiochemical and Biophysical Research Communications, 2009
- Thermosensation and painJournal of Neurobiology, 2004